Table 4 The pathogen related mortality and the ratio of inadequate antibiotics

Gram(+) bacteria

Staphylococcus aureus

21/38 (55.3%)

25/38 (65.8%)

0.011

  MSSA

1/7 (14.3%)

0/7 (0.0%)

-

  MRSA

20/31 (64.5%)

25/31 (80.6%)

0.151

Coagulase-negative Staphylococcus

3/5 (60.0%)

3/5 (60.0%)

1.000

Beta-hemolytic Streptococcus (Non Group A or B)

0/1 (0.0%)

0/1 (0.0%)

-

Streptococcus pneumoniae

2/2 (100.0%)

0/2 (0.0%)

-

Viridans Streptococcus

2/3 (66.7%)

0/3 (0.0%)

-

Enterococcus faecalis

5/10 (50.0%)

9/10 (90.0%)

1.000

Corynebacterium spp.

0/7 (0.0%)

3/7 (42.9%)

-

Enterobacteriaceae

Escherichia coli

16/42 (38.1%)

21/42 (50.0%)

0.340

Klebsiella pneumoniae

21/34 (61.8%)

23/34 (67.6%)

1.000

Proteus mirabilis

4/10 (40.0%)

6/10 (60.0%)

1.000

Enterobacter cloacae

0/1 (0.0%)

1/1 (100.0%)

-

Enterobacter aerogenes

3/6 (50.0%)

4/6 (66.7%)

0.400

Serratia marcescens

2/4 (50.0%)

3/4 (75.0%)

1.000

Non-typhoidal Salmonella

1/4 (25.0%)

2/4 (50.0%)

1.000

Providencia rettgeri

1/3 (33.3%)

2/3 (66.7%)

0.333

Morganella morganii

0/3 (0.0%)

1/3 (33.3%)

-

Citrobacter spp.

1/1 (100.0%)

1/1 (100.0%)

-

Haemophilus influenzae

1/1 (100.0%)

1/1 (100.0%)

-

Glucose Non-fermenter

Pseudomonas aeruginosa

4/7 (57.1%)

5/7 (71.4%)

1.000

Burkholderia cepacia

8/23 (34.8%)

12/23 (52.2%)

0.193

Acinetobacter baumannii

6/8 (75.0%)

5/8 (62.5%)

1.000

Stenotrophomonas maltophilia

1/1 (100.0%)

0/1 (0.0%)

-

Anaerobes

Peptostreptococcus spp.

0/2 (0.0%)

1/2 (50.0%)

-

Propionibacterium spp.

0/4 (0.0%)

2/4 (50.0%)

-

Candida spp

2/2 (100.0%)

1/2 (50.0%)

-